Where does Thomas Cahill work?

Thomas Cahill is Founder and Managing Partner at Newpath Partners and Founder at Autobahn Therapeutics, Inc. and Founder at Avelo and Founder at Kojin Therapeutics.

What does Thomas Cahill invest in?

Thomas Cahill invests in Biotech, Healthtech, Medical Devices.

What check size does Thomas Cahill write?

Thomas Cahill typically writes checks of $50K – $10M.

Thomas Cahill

InvestorFounder

Founder and Managing Partner at Newpath Partners · Founder at Autobahn Therapeutics, Inc. · Founder at Avelo · Founder at Kojin Therapeutics

Writes $50K – $10M checks

FoundedAutobahn Therapeutics, Inc.Avelo Kojin Therapeutics

About

Physician-scientist (M.D./Ph.D., Duke) and co-founder building companies around transformational science, partnering early with academic stars and using a founder-of-founders model to align scientists and teams in gene editing and epigenetics.

Invests in

BiotechHealthtechMedical Devices

Founder at Autobahn Therapeutics, Inc.

Intro paths

→

In turn, Thomas can intro founders to Autobahn Therapeutics, Inc.'s investors below.

Autobahn Therapeutics, Inc.'s investors · 6

ARCH Venture PartnersChicago · $50K – $250M checks · since 2024 Canaan PartnersStamford · $500K – $20M checks · since 2024 Monograph Capital PartnersLondon · since 2024 Newpath PartnersBoston · $50K – $10M checks · since 2024 Pfizer Venture Investments$5M – $20M checks · since 2024 Samsara BioCapitalPalo Alto · since 2024

Co-founders at Autobahn Therapeutics, Inc.

Kevin FinneyChairman, President and CEO

John BorkholderExecutive Officer

Founder at Avelo

Intro paths

→

In turn, Thomas can intro founders to Avelo's investors below.

Avelo's investors · 1

Newpath PartnersBoston · $50K – $10M checks · since 2025

Co-founders at Avelo

Andrew C. LevyChief Executive Officer

Hunter KeayChief Financial Officer

Robert AshcroftDirector

Miguel HerasDirector

Founder at Kojin Therapeutics

Intro paths

→

In turn, Thomas can intro founders to Kojin Therapeutics's investors below.

Kojin Therapeutics's investors · 1

Newpath PartnersBoston · $50K – $10M checks · since 2021

Co-founders at Kojin Therapeutics

Nagesh Mahanthappa, Ph.D.Director

Luba GreenwoodDirector

Colleagues at Newpath Partners

Daniel Yadegar

Co-Founder and Chief Medical Officer at Newpath Partners

Tom Thomas

Principal at Newpath Partners

Frequently asked questions

Where does Thomas Cahill work?: Thomas Cahill is Founder and Managing Partner at Newpath Partners and Founder at Autobahn Therapeutics, Inc. and Founder at Avelo and Founder at Kojin Therapeutics.
What does Thomas Cahill invest in?: Thomas Cahill invests in Biotech, Healthtech, Medical Devices.
What check size does Thomas Cahill write?: Thomas Cahill typically writes checks of $50K – $10M.
What companies did Thomas Cahill found?: Thomas Cahill founded Autobahn Therapeutics, Inc., Avelo, Kojin Therapeutics.